News
-
Leiden-developed drug candidate ready for final clinical trial phaseImpact 27 May 2025Bringing your drug candidates to patients is what many academic chemists dream about, but the road to this goal is long and bumpy. Now, Leiden small m...
-
How to hijack natural destruction in cells: ‘We need to understand it through and through’05 September 2024Destroying proteins from the Golgi apparatus of the cell in a controlled manner. That is the focus of chemist Marta Artola’s pioneering research. By d...
-
How Leiden researchers are going to fight Gaucher's disease with a start-up07 April 2020It has kept Leiden professor Hans Aerts busy throughout his academic career: Gaucher's disease, a hereditary metabolic disease. Together with professo...
-
Translating science into treatments of rare metabolic disorders06 February 2020Leiden biotech startup Azafaros has successfully completed a funding round, raising 25 million euros of investments for developing treatments of rare ...
-
Nine CMR-chemicals are added to the list of substances of very high concern (for health, environment)07 March 2019
The organization RIVM has recently updated the Dutch list of so-called substances of very high concern and has added 9 CMR chemicals to their list.
-
FameLab: young scientists take the stage26 February 2019In FameLab contestants explain their research to the public in a three-minute presentation – without using PowerPoint or other presentation tools. The...
-
Breakthrough by Leiden researchers in Pompe disease02 May 2016Researchers at Leiden University have made a breakthrough in the study of the hereditary Pompe disease. Together with colleagues in York, they have de...